Calming exercises can help tame anxiety, but a creative life is a cure-all according to author Martha Beck: “Anxiety can’t ...

Mind Medicine (MNMD) announced that the first patient has been dosed in Panorama, its second Phase 3 study evaluating MM120 ...

AI-driven tools harness ML algorithms to provide insights into anxiety disorders. Supervised ML models, such as logistic ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study results, an analyst ...

“Hyperthyroidism is often linked to Graves’ disease, another autoimmune condition that overstimulates the thyroid. Thyroid nodules, which are abnormal lumps in the thyroid, and excessive iodine can ...

The MM120 ODT Phase 3 clinical development program also includes the Voyage study for GAD and the Emerge study for major depressive disorder (MDD). The U.S. Food and Drug Administration has granted ...

Antidepressants, such as Prozac, are already used to treat the condition but Canadian and Italian scientists set out to ...

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under trial conditions, although there is limited data on long-term usage.

A new Cochrane review confirms that antidepressants effectively reduce symptoms of generalized anxiety disorder (GAD) under ...

Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.

A new study from the Texas A&M University School of Public Health provides additional evidence that meditation using ...